1,567 followers
Updated Overall Survival of #Ribociclib plus Endocrine Therapy versus #Endocrine Therapy Alone in Pre- and #Perimenopa… https://t.co/FBDFnYoU85
19,207 followers
Join us now @TwitterSpaces to discuss! #bcsm #BrownJC
19,207 followers
First, @LauraSalamaMD is going to review MONALEESA-7, which should help get us in the mood to consider NATALEE after that press release ‼️ #BrownJC #bcsm https://t.co/l8GP1Yx5f6
168 followers
The authors of "Updated Overall Survival of Ribociclib plus Endocr…" (https://t.co/9KoDjPVYUp) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #accelerateopenscience #reproducibility
1,211 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
6,779 followers
Phase 3 Study: Updated Overall Survival Analysis of the MONALEESA-7 Trial. https://t.co/Zsp0Ia7LvT https://t.co/HgRN3eDqjP
239 followers
RT @BCancerAcademy: Nuovi materiali! 📚DALLA LETTERATURA MONALEESA-7: trial di fase 3 che ha valutato la combo di ribociclib e terapia endoc…
156 followers
RT @BCancerAcademy: Nuovi materiali! 📚DALLA LETTERATURA MONALEESA-7: trial di fase 3 che ha valutato la combo di ribociclib e terapia endoc…
35 followers
RT @BCancerAcademy: Nuovi materiali! 📚DALLA LETTERATURA MONALEESA-7: trial di fase 3 che ha valutato la combo di ribociclib e terapia endoc…
587 followers
Nuovi materiali! 📚DALLA LETTERATURA MONALEESA-7: trial di fase 3 che ha valutato la combo di ribociclib e terapia endocrina nel ca mammario avanzato ER+/HER2- in pre-o perimenopausa Di @GarufiGiovanna, Roma #breastcancer https://t.co/lsiumSxGaf https:/
7,428 followers
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial https://t.co/LUiC9jsQxQ
6,779 followers
#Ribociclib plus endocrine therapy result in longer #OverallSurvival than ET alone in pre-/perimenopausal patients with HR+/HER2– advanced #BreastCancer study. https://t.co/J4bkg1CTQe @pwheatleyprice https://t.co/nJ6cIPIK8D
588 followers
RT @NatRevClinOncol: Long follow-up data from the phase III MONALEESA-7 trial confirm that the addition of ribociclib to endocrine therapy…
40,083 followers
Long follow-up data from the phase III MONALEESA-7 trial confirm that the addition of ribociclib to endocrine therapy for patients with advanced-stage HR+, HER2− #breastcancer results in superior OS: median 58.7 vs 48.0 months in the placebo group https://
731 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
137 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
6,779 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
33,813 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
5 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
147 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
30 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
14 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
64 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
311 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
3,640 followers
483 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
900 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
370 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
1,019 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
417 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
281 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
134 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
389 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
83 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
34,455 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
76 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
3,346 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
2,438 followers
RT @matteolambe: Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial…
14,236 followers
Two important news for premenopausal women with #BreastCancer to close 2021: 1) Updated OS results from #MONALEESA7 trial https://t.co/HCY2VgYpOo 2) Large RCT showing gonadal protection for #GnRHa during #chemotherapy https://t.co/nJLMHDM4lk @OncoAlert
299 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
220 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
1,975 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
417 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
1,332 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
298 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
56 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
57 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
345 followers
RT @aLwOmbaT: 58.7 m 😎
6,779 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
3,592 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
410 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
1,156 followers
58.7 m 😎
1,106 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
11 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
2,645 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
703 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
1,597 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
311 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
2,438 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
4,819 followers
RT @PTarantinoMD: Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with riboc…
21,939 followers
Updated OS from #MONALEESA7 just out on @CCR_AACR After 4.5 years of follow up, OS was significantly improved with ribociclib, reaching a median of nearly 5y (58.7 vs 48 months) https://t.co/zx4IuR9NW3 https://t.co/63eZuGha1v
7,428 followers
Updated Overall Survival of Ribociclib Plus Endocrine Therapy vs Endocrine Therapy Alone in Pre- and Perimenopausal Patients With HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial https://t.co/6dONbjrd83